The effect of RPL39 on pancreatic cancer cell apoptosis seems to be dependent on caspase 8 activation suggesting that targeting RPL39 could be a potential treatment in pancreatic cancer [105]. This evidence concerns the gene RPL39 and familial pancreatic carcinoma.